Company / Inventory
10x Genomics, Inc. Inventory History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$56.3M
FY2025
5-year range
$56.3M / $83.1M
FY2021-FY2025
Trend
-32.2%
vs FY2024
Sector context
#89 of 118
Health Care
What the data says
10x Genomics, Inc.'s inventory of $56M is lower than 75% of companies in the Health Care sector (FY2025). Inventory has fluctuated over the past 8 years, ranging from $9M in FY2018 to $83M in FY2024.
Based on SEC 10-K filings.
$56M in FY2025 with a 5-year CAGR of +13.5%.
Declined from $74M to $56M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -11.6%
- 5-Year CAGR
- +13.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 118This company $56.3M Sector average $1.4B
▼
-96.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +13.5%, indicating consistent growth.
- In FY2025, inventory decreased 32.2% year-over-year.
- Ranks #89 out of 118 companies in the Health Care sector.
- Peak inventory was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $56.3M | -32.2% |
| FY2024 | $83.1M | +12.8% |
| FY2023 | $73.7M | -9.7% |
| FY2022 | $81.6M | +36.1% |
| FY2021 | $60.0M | +100.2% |
| FY2020 | $30.0M | +96.2% |
| FY2019 | $15.3M | +78.2% |
| FY2018 | $8.6M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026